Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clio P Mavragani

Showing results (11-20 of 117) with videos related to

Pageof 12
Sort By:
European Journal of Internal Medicine|August 9, 2005
Is polydipsia sometimes the cause of oxcarbazepine-induced hyponatremia?Clio P Mavragani, Panayiotis G Vlachoyiannopoulos
Journal of Autoimmunity|August 3, 2010
Activation of the type I interferon pathway in primary Sjogren's syndromeClio P Mavragani, Mary K Crow
Clinical Case Reports|September 5, 2020
A case of antisynthetase syndromeClio P Mavragani, Haralampos M Moutsopoulos
Autoimmunity Reviews|November 12, 2009
The geoepidemiology of Sjögren's syndromeClio P Mavragani, Haralampos M Moutsopoulos
Physiological Reviews|July 10, 2025
Type I interferons in health and disease: molecular aspects and clinical implicationsClio P Mavragani, Mary K Crow
Expert Review of Clinical Immunology|January 18, 2019
B cells and atherosclerosis in systemic lupus erythematosusVasiliki Koulouri, Michael Koutsilieris, Clio P Mavragani
Mediterranean Journal of Rheumatology|May 25, 2022
The Immunomodulatory Properties of Vitamin DLambros Athanassiou, Clio P Mavragani, Michael Koutsilieris
American Journal of Hematology|April 1, 2003
Pure red cell aplasia in a Sjögren's syndrome/lupus erythematosus overlap patientClio P Mavragani, Eythymia Vlachaki, Michalis Voulgarelis
Clinical and Experimental Rheumatology|November 18, 2017
Psychological comorbidities associated with subclinical atherosclerosis in Greek patients with primary Sjögren's syndrome: a potential contribution of sleep impairmentTheofanis Karageorgas, Dimitrios Ioakeimidis, Clio P Mavragani
Journal of Clinical Medicine|January 21, 2022
Sjogren's Syndrome: Recent UpdatesCharalampos Skarlis, Sylvia Raftopoulou, Clio P Mavragani
Pageof 12

Showing results (11-20 of 117) with videos related to

Sort By:
Pageof 12
European Journal of Internal Medicine|August 9, 2005
Is polydipsia sometimes the cause of oxcarbazepine-induced hyponatremia?Clio P Mavragani, Panayiotis G Vlachoyiannopoulos
Journal of Autoimmunity|August 3, 2010
Activation of the type I interferon pathway in primary Sjogren's syndromeClio P Mavragani, Mary K Crow
Clinical Case Reports|September 5, 2020
A case of antisynthetase syndromeClio P Mavragani, Haralampos M Moutsopoulos
Autoimmunity Reviews|November 12, 2009
The geoepidemiology of Sjögren's syndromeClio P Mavragani, Haralampos M Moutsopoulos
Physiological Reviews|July 10, 2025
Type I interferons in health and disease: molecular aspects and clinical implicationsClio P Mavragani, Mary K Crow
Expert Review of Clinical Immunology|January 18, 2019
B cells and atherosclerosis in systemic lupus erythematosusVasiliki Koulouri, Michael Koutsilieris, Clio P Mavragani
Mediterranean Journal of Rheumatology|May 25, 2022
The Immunomodulatory Properties of Vitamin DLambros Athanassiou, Clio P Mavragani, Michael Koutsilieris
American Journal of Hematology|April 1, 2003
Pure red cell aplasia in a Sjögren's syndrome/lupus erythematosus overlap patientClio P Mavragani, Eythymia Vlachaki, Michalis Voulgarelis
Clinical and Experimental Rheumatology|November 18, 2017
Psychological comorbidities associated with subclinical atherosclerosis in Greek patients with primary Sjögren's syndrome: a potential contribution of sleep impairmentTheofanis Karageorgas, Dimitrios Ioakeimidis, Clio P Mavragani
Journal of Clinical Medicine|January 21, 2022
Sjogren's Syndrome: Recent UpdatesCharalampos Skarlis, Sylvia Raftopoulou, Clio P Mavragani
Pageof 12